Forbes: NIH Trial Gives Surprising Boost To Chelation Therapy

With a result that is likely to surprise and baffle much of the mainstream medical community, a large NIH-sponsored trial has turned up the first substantial evidence in support of chelation therapy for patients with coronary disease. Known as TACT (Trial to Assess Chelation Therapy),  the highly controversial trial was presented today at the AHA by Gervasio […]

ACAM: Position Paper on EDTA Chelation Therapy

[While ACAM is standing up for IV chalation with excellent arguments for its benefits, they fail to mention the other type of chelations administered orally and in the form of suppository. Even with these shortcomings, the Position Paper clearly out lines the tremendous potential of chelation for wellbeing – the editor.] Table of Contents Introduction […]